| NCT ID | NCT04925427 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Opioid Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2021-08-10 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,500 participants in total. It began in 2021-08-10 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Reducing Opioid Mortality in Illinois (ROMI) is 5-year research study led by the University of Chicago in partnership with the University of Illinois at Chicago's (UIC) Community Outreach Intervention Projects (COIP), the Illinois Criminal Justice Information Authority (ICJIA) and the American Institutes for Research (AIR). ROMI aims to understand and test strategies for linking individuals with a history of opioid use disorder who are released from Illinois jails and prisons to substance use treatment. ROMI is one of twelve grants awarded by the National Institutes of Health (NIH) as part of the Justice Community Opioid Innovation Network (JCOIN) to support research on quality addiction treatment for opioid use disorder in criminal justice settings nationwide.
Eligibility Criteria
Inclusion Criteria: * Participants must be at least 18 years old * Reside in designated research site county or zip code * Satisfy criteria for likely OUD based upon nonmedical use of prescription opioids, heroin, or synthetic opioids. Exclusion Criteria: * Participants experiencing cognitive impairments that preclude informed consent. * Reside out of the service area. * Prior enrollment in a parallel JCOIN study.
Contact & Investigator
Harold Pollack, PhD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT04925427 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04925427 currently recruiting?
Yes, NCT04925427 is actively recruiting participants. Contact the research team at haroldp@uchicago.edu for enrollment information.
Where is the NCT04925427 trial being conducted?
This trial is being conducted at Chicago, United States, Murphysboro, United States, Ottawa, United States, Springfield, United States and 1 additional location.
Who is sponsoring the NCT04925427 clinical trial?
NCT04925427 is sponsored by University of Chicago. The principal investigator is Harold Pollack, PhD at University of Chicago. The trial plans to enroll 1,500 participants.